---
annotations:
- type: Pathway Ontology
  value: '"Wnt signaling'
authors:
- ReactomeTeam
- Mkutmon
description: Humans and mice have 19 identified WNT proteins that were originally
  classified as either 'canonical' or 'non-canonical' depending upon whether they
  were able to transform the mouse mammary epithelial cell line C57MG and to induce
  secondary axis formation in Xenopus (Wong et al, 1994; Du et al, 1995).  So-called
  canonical WNTs, including Wnt1, 3, 3a and 7, initiate signaling pathways that destabilize
  the destruction complex and allow beta-catenin to accumulate and translocate to
  the nucleus where it promotes transcription (reviewed in Saito-Diaz et al, 2013).  Non-canonical
  WNTs, including Wnt 2, 4, 5a, 5b, 6, 7b, and Wnt11 activate beta-catenin-independent
  responses that regulate many aspects of morphogenesis and development, often by
  impinging on the cytoskeleton (reviewed in van Amerongen, 2012).  Two of the main
  beta-catenin-independent pathways are the Planar Cell Polarity (PCP) pathway, which
  controls the establishment of polarity in the plane of a field of cells, and the
  WNT/Ca2+ pathway, which promotes the release of intracellular calcium and regulates
  numerous downstream effectors (reviewed in Gao, 2012; De, 2011).  View original
  pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=3858494 Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3558
- /instance/WP3558
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3558.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Humans and mice have 19 identified WNT proteins that were originally
    classified as either 'canonical' or 'non-canonical' depending upon whether they
    were able to transform the mouse mammary epithelial cell line C57MG and to induce
    secondary axis formation in Xenopus (Wong et al, 1994; Du et al, 1995).  So-called
    canonical WNTs, including Wnt1, 3, 3a and 7, initiate signaling pathways that
    destabilize the destruction complex and allow beta-catenin to accumulate and translocate
    to the nucleus where it promotes transcription (reviewed in Saito-Diaz et al,
    2013).  Non-canonical WNTs, including Wnt 2, 4, 5a, 5b, 6, 7b, and Wnt11 activate
    beta-catenin-independent responses that regulate many aspects of morphogenesis
    and development, often by impinging on the cytoskeleton (reviewed in van Amerongen,
    2012).  Two of the main beta-catenin-independent pathways are the Planar Cell
    Polarity (PCP) pathway, which controls the establishment of polarity in the plane
    of a field of cells, and the WNT/Ca2+ pathway, which promotes the release of intracellular
    calcium and regulates numerous downstream effectors (reviewed in Gao, 2012; De,
    2011).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=3858494
    Reactome].
  keywords:
  - N4GlycoAsn-PalmS
  - WNT5A/11:FZD:G-protein (alpha o/t2) inactive
  - 'PSMD5 '
  - WNT
  - Heterotrimeric
  - 'pT201,T212-TCF7L2 '
  - signaling in
  - transcripts
  - G-protein
  - 'miR-92b '
  - TCF dependent
  - kinase C (alpha,
  - 'GNB5 '
  - 'pp-DVL1 '
  - WNT:FZD
  - 'pT155,S166-LEF1 '
  - PCP pathway WNTs
  - WNT5A:FZD
  - 'PSMD2 '
  - 'PLCB2 '
  - 'FZD5 '
  - 'GNB3 '
  - 'TNRC6A '
  - GMP
  - PRKG homodimer:cGMP
  - N4GlycoAsn-PalmS-WNT5A:RYK:VANGL2
  - 'SMURF1 '
  - WNT5A:FZD4:p-DVL2
  - 'UBC(457-532) '
  - target genes
  - 'TCF7L2 '
  - 'RAC2 '
  - 'PSME2 '
  - cGMP
  - 'PSMD14 '
  - 'UBB(77-152) '
  - PCP pathway FZDs
  - 'ITPR1 '
  - WNT:FZD:pDVL
  - pT298-NLK dimer
  - WNT5A:FZD4:p-DVL2:AP-2:clathrin
  - 'pS5,S82,S84-VANGL2 '
  - 'p-T286-CAMK2A '
  - NFATC1:CaN:CaM
  - (o/t2)
  - 'UBB(153-228) '
  - WNT5A:ROR2:p-VANGL2
  - WNT/Ca2+ FZDs
  - p-DVL
  - 'DAAM1 '
  - 'UBB(1-76) '
  - Pi
  - 'AP2A2(1-939) '
  - 'FZD1 '
  - PFN1
  - H2O
  - 'TNRC6B '
  - 'UBC(1-76) '
  - N4GlycoAsn-PalmS-WNT5A:FZD4
  - 'PSME3 '
  - 'AXIN2 mRNA '
  - p-T497,T638,S657-PRKCA
  - 'PS '
  - 'GNG11 '
  - G-protein alpha
  - MAP3K7
  - 'UBC(533-608) '
  - 'TCF7 '
  - 'PSMB9 '
  - 'PSME1 '
  - PI(4,5)P2
  - 'ARRB2 '
  - 'AXIN2 gene '
  - ATP
  - CALM1:4xCa2+
  - Ca2+
  - complex
  - 'GNGT1 '
  - SCRIB
  - 'pp-DVL2 '
  - 'RAC1 '
  - NLK mRNA
  - 'SHFM1 '
  - 'N4GlycoAsn-PalmS WNT5A(36-380) '
  - 'PPP3CB '
  - 'SMURF2 '
  - KRAS4B:CALM1:4xCa2+
  - PRICKLE1
  - 'PDE6B '
  - 'PSMC3 '
  - 'PDE6A '
  - PARD6A:pp-DVL2:SMURF
  - 'TNRC6C '
  - 'AP2B1 '
  - 'GTP '
  - 'PFN1 '
  - 'GDP '
  - 'PRKCB '
  - beta, gamma
  - 'CALM1 '
  - Ub
  - ROR2
  - 'EIF2C1 '
  - Calcineurin (CaN)
  - 'I(1,4,5)P3 '
  - S-Farn-Me
  - 'PARD6A '
  - isoforms)
  - 'PPP3CA '
  - 'PSMD10 '
  - p-T286 CAMK2:CaM
  - 'DAG '
  - 'PSMF1 '
  - 'S-Farn-Me KRAS4B '
  - 'pT497,T638,S657-PRKCA '
  - 'VANGL2 '
  - 'ITPR2 '
  - 'GNG8 '
  - 'RHOA '
  - RISC
  - Calcineurin:Calmodulin (CaN:CaM)
  - ARRB2
  - 'PSMC5 '
  - GDP
  - 'PSMD3 '
  - 'GNG12 '
  - DVL2
  - 'EIF2C4 '
  - GTP
  - G-protein (o/t2)
  - 'ROR2 '
  - 'N4GlycoAsn-PalmS WNT1 '
  - pp-DVL:RAC:GTP
  - 'UBC(381-456) '
  - VANGL2
  - 'PSMD4 '
  - 'PSMB5 '
  - WNT5A:FZD4:DVL2
  - 'EIF2C3 '
  - 'AGO2 '
  - miR-92b RISC
  - 'PSMD1 '
  - 'GNGT2 '
  - WNT5A:FZDs/ROR
  - 'PLCB1 '
  - p-TCF/LEF:CTNNB1
  - p-T187-MAP3K7
  - 'PSMC2 '
  - 'GNG7 '
  - FZD4
  - 'PSMB4 '
  - 'PRKG2 '
  - 'GNG4 '
  - 'PSMA8 '
  - 'SCRIB '
  - 'PSMD8 '
  - PS
  - ADP
  - WNT5A:ROR2:VANGL2
  - CAMK2A
  - 'CLTA '
  - beta-gamma:PLC beta
  - 'GNB1 '
  - 'PSMC6 '
  - 'PSME4 '
  - 'PSMA6 '
  - 'GNB2 '
  - RAC:GTP
  - 'GNAO1 '
  - WNT5A/WNT11
  - '''canonical'' WNT'
  - p-12S-NFATC1
  - 'PDE6G '
  - 'UBC(153-228) '
  - 'PLCB3 '
  - 'p-DVL3 '
  - 'PSMA5 '
  - Activated Protein
  - activated PKC alpha
  - 'Mg2+ '
  - ITPR:I(1,4,5)P3
  - 'RAC3 '
  - target
  - 'GNG2 '
  - 'p-S257-NFATC1 '
  - 'Fe3+ '
  - 'ROR1 '
  - 'MAP3K7 '
  - 'MYC gene '
  - ppDVL:DAAM1:PFN1
  - 'Ca2+ '
  - 'CTNNB1 '
  - DAAM1
  - 'UBC(609-684) '
  - VANGL2:SCRIB:FZD3
  - 'PSMA4 '
  - 'UBC(77-152) '
  - clathrin:AP-2
  - 'PRKCG '
  - 'PSMB10 '
  - 'p-T298-NLK '
  - 'PSMD9 '
  - 'RYK '
  - CAMK2:CaM
  - I(1,4,5)P3
  - 'CLTB '
  - 'GNAT2 '
  - GNAT2:GTP
  - 'PSMC1 '
  - 'PSMB2 '
  - 'p-T286,T305,T306-CAMK2A '
  - NLK
  - genes:TCF/LEF:CTNNB1
  - 'PSMB3 '
  - PLC-beta 1/2/3
  - response to WNT
  - target gene
  - WNT5A/11:FZD
  - SMURF
  - 'GNG5 '
  - 'FZD4 '
  - 'NLK mRNA '
  - G-protein beta-gamma
  - 'GNG3 '
  - (inactive)
  - 'PSMA7 '
  - 'FZD3 '
  - 'CLTC '
  - 'FZD8 '
  - PDE6
  - 'ITPR3 '
  - 'PRKCA '
  - 'Zn2+ '
  - WNT5A(36-380)
  - 26S proteasome
  - 'pp-DVL3 '
  - 'AP2S1 '
  - unknown kinase
  - 'PSMB11 '
  - 'UBA52(1-76) '
  - NLK mRNA:miR-92b
  - 'UBC(229-304) '
  - FZD3
  - 'PSMD6 '
  - 'PSMD11 '
  - 'RPS27A(1-76) '
  - GNAT2:PDE6
  - 'N4GlycoAsn-PalmS WNT5B '
  - WNT5A-binding FZDs
  - homotetramer
  - IP3 receptor
  - PARD6A:pp-DVL2
  - ub-PRICKLE1
  - 'MYC mRNA '
  - 'AP2M1 '
  - ppDVL:DAAM1
  - 'PSMB8 '
  - DAG
  - 'DVL2 '
  - '''canonical'''
  - FZD2/FZD5/ROR2
  - 'GNB4 '
  - 'GNG10 '
  - RHOA:GTP:Mg2+
  - pp-DVL
  - 'UBC(305-380) '
  - 'PSMA2 '
  - TCF/LEF:CTNNB1
  - 'PSMB7 '
  - 1/2/3
  - RYK
  - 'MOV10 '
  - 'FZD7 '
  - 'PSMA3 '
  - 'cGMP '
  - 'PSMD7 '
  - 'CAMK2A '
  - 'PSMD12 '
  - WNT5A:FZD4:p-DVL2:ARRB2:AP-2:clathrin
  - 'GNG13 '
  - 'FZD2 '
  - 'p-S-DVL1 '
  - 'p-DVL2 '
  - VANGL2:SCRIB
  - 'AP2A1 '
  - 'TCF7L1 '
  - 'PPP3R1 '
  - tetramer
  - 'PSMC4 '
  - PARD6A:p-DVL2
  - 'FZD6 '
  - p-T286,305,306-CAMK2:MAP3K7
  - PRKG dimer
  - 'N4GlycoAsn-PalmS WNT4 '
  - 'PSMB6 '
  - 'PSMB1 '
  - 'PSMA1 '
  - 'LEF1 '
  - ppDVL:DAAM1:RHOA:GTP
  - 'PSMD13 '
  - 'PRKG1 '
  - 'N4GlycoAsn-PalmS WNT11 '
  - p-T286,T305,T306-CAMK2A
  - WNT5A/11:FZD:G-protein (alpha o/t2) active
  license: CC0
  name: Beta-catenin independent WNT signaling
seo: CreativeWork
title: Beta-catenin independent WNT signaling
wpid: WP3558
---